Immunic IMUX Balance Sheet (2013-2026)

NASDAQ IMUX
$12.78 +0.02 (+0.20%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Immunic Quarterly Balance Sheet

Periods 54 quarters
Latest Jun 2026

Immunic reported total assets of $159.17M and total liabilities of $31.59M for the quarter ended Jun 2026, up 159.1% year over year. This balance sheet covers 54 quarters of results from Mar 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
110.44M86.86M95.71M88.10M72.77M106.75M92.76M77.30M59.70M46.67M97.31M79.70M59.07M35.67M14.30M55.31M35.13M15.48M186.63M155.10M
Prepaid Assets
12.05M18.12M20.17M16.68M13.88M9.49M9.47M9.26M5.54M5.86M5.30M5.28M4.20M3.66M4.67M4.53M4.14M7.39M2.13M2.73M
Current Assets
122.50M104.99M115.88M104.76M86.65M125.86M106.58M86.55M65.23M52.53M102.61M84.98M63.27M39.33M18.98M59.84M39.27M22.87M188.76M157.83M
Non-Current Assets
Property, Plant & Equipment (Net)
0.20M0.15M0.15M0.14M0.16M0.29M0.29M0.29M0.29M0.47M0.44M0.58M0.62M0.55M0.57M0.61M0.64M0.61M0.57M0.77M
Goodwill
32.97M32.97M32.97M32.97M32.97M
Goodwill & Intangibles
32.97M32.97M32.97M32.97M32.97M
Other Non-Current Assets
0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M
Non-Current Assets
34.26M34.11M34.04M33.90M34.43M1.89M2.29M2.19M1.74M1.76M1.54M1.51M1.50M1.54M1.54M1.59M1.43M1.18M0.98M1.34M
Assets
156.76M139.10M149.92M138.66M121.08M127.75M108.87M88.74M66.98M54.30M104.16M86.49M64.76M40.87M20.52M61.43M40.70M24.05M189.74M159.17M
Liabilities
Current Liabilities
Accounts Payables
3.24M3.75M3.29M4.12M4.17M4.28M5.24M4.70M3.20M5.10M6.77M7.89M6.04M7.85M6.01M7.89M7.92M10.14M11.01M12.66M
Payables
3.24M3.75M3.29M4.12M4.17M4.28M5.24M4.70M3.20M5.10M6.77M7.89M6.04M7.85M6.01M7.89M7.92M10.14M11.01M12.66M
Accumulated Expenses
6.77M7.07M7.52M5.74M6.62M7.99M10.18M12.61M13.66M18.66M12.42M13.78M16.25M12.91M18.29M18.11M19.45M18.64M22.43M17.85M
Other Accumulated Expenses
0.58M0.58M0.65M0.54M0.72M0.81M0.88M0.93M0.92M0.97M0.96M1.01M1.07M1.42M1.29M1.31M2.71M1.83M4.92M0.74M
Total Current Liabilities
10.59M11.40M11.46M10.40M11.51M13.08M16.30M18.24M17.78M24.73M20.15M22.68M23.36M22.18M25.59M27.31M30.08M30.62M38.36M31.26M
Non-Current Liabilities
Preferred Stock Liabilities
Minority Interest
Operating Leases
1.14M0.58M0.91M0.77M1.27M0.99M2.00M1.88M1.45M0.64M1.13M0.95M0.90M0.26M0.97M0.98M0.79M0.11M0.42M0.57M
Other Non-Current Liabilities
Total Non-Current Liabilities
0.70M0.58M0.50M0.41M0.76M0.99M1.35M1.21M0.79M0.64M0.43M0.24M0.19M0.26M0.21M0.20M0.13M0.11M0.15M0.33M
Total Liabilities
11.29M11.98M11.96M10.81M12.27M14.07M17.65M19.45M18.57M25.37M20.58M22.92M23.54M22.44M25.80M27.52M30.20M30.73M38.51M31.59M
Shareholder's Equity
Common Equity
145.47M127.11M137.96M127.85M108.81M113.68M91.22M69.28M48.41M28.93M83.58M63.57M41.22M18.43M-5.29M33.91M10.50M-6.67M151.23M127.58M
Liabilities and Shareholders Equity
156.76M139.10M149.92M138.66M121.08M127.75M108.87M88.74M66.98M54.30M104.16M86.49M64.76M40.87M20.52M61.43M40.70M24.05M189.74M159.17M
Retained Earnings
321.95M324.24M355.95M368.09M370.00M427.93M429.95M431.85M433.82M436.06M519.76M521.64M523.55M525.61M-536.90M595.07M597.18M-608.60M789.32M800.05M
Treasury Shares